Table 5.
Characteristics of infection in patients with IAC (N = 17).
| N (%) or median (interquartile range) | |
|---|---|
| Candidemia | 2 (11.8) |
| Candida albicans | 1 (5.9) |
| Candida glabrata | 1 (5.9) |
| Bacteremia | 1 (5.9) |
| Bacterial culture in PF | |
| Gram-negative bacilli | 6 (35.3) |
| Gram-positive cocci | 6 (35.3) |
| No bacterial isolation | 7 (41.2) |
| Broad-spectrum antibiotic therapy | 17 (100.0) |
| Fungal culture in PF a | |
| Candida albicans | 8 (47.1) |
| Candida glabrata | 3 (17.6) |
| Candida tropicalis | 3 (17.6) |
| Candida krusei | 1 (5.9) |
| No fungal isolation | 3 (17.6) |
| Fungal smear microscopy in PF | |
| Positive | 2 (11.8) |
| Negative | 15 (88.2) |
| Candida spp. identification by PCR in PF | |
| Candida albicans | 4 (23.5) |
| Candida glabrata | 4 (23.5) |
| Candida tropicalis | 2 (11.8) |
| Candida krusei | 1 (5.9) |
| No fungal isolation | 6 (35.3) |
| Initial antifungal drugs b | |
| Micafungin | 7 (41.2) |
| Caspofungin | 7 (41.2) |
| Voriconazole | 1 (5.9) |
| Fluconazole | 1 (5.9) |
| Duration of antifungal therapy (days) | 4 (0–10) |
Results are presented as n (%) or median (interquartile range). IAC, intra-abdominal candidiasis; PF, peritoneal fluids. aBoth Candida glabrata and Candida tropicalis were reported in fungal culture in one IAC patient; bOne patient with IAC died before antifungal therapy was initiated.